Role of Cartilage-Associated Protein in Skeletal Development

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Current Osteoporosis Reports

• Publication date

  2010-04-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11914-010-0010-7PMID 20425614PMCID PMC6986317
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PPIB mutations cause severe osteogenesis imperfecta.

  2009cited by this paper
• A Missense Mutation in the SERPINH1 Gene in Dachshunds with Osteogenesis Imperfecta

  2009cited by this paper
• Chapter 6. The Composition of Bone

  2009cited by this paper
• Biochemical Characterization of the Prolyl 3-Hydroxylase 1·Cartilage-associated Protein·Cyclophilin B Complex*

  2009cited by this paper
• CRTAP mutations in lethal and severe osteogenesis imperfecta: the importance of combining biochemical and molecular genetic analysis

  2009cited by this paper
• Intravenous Pamidronate in Osteogenesis Imperfecta Type VII

  2009cited by this paper
• Popcorn calcification in osteogenesis imperfecta: Incidence, progression, and molecular correlation

  2008cited by this paper
• CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta

  2008cited by this paper
• Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype–phenotype relationships

  2008cited by this paper
• Effect of the ‐Gly‐3(S)‐hydroxyprolyl‐4(R)‐hydroxyprolyl‐ tripeptide unit on the stability of collagen model peptides

  2008cited by this paper
• Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta

  2007cited by this paper
• Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta.

  2006cited by this paper
• CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta.

  2006cited by this paper
• Type V Collagen Controls the Initiation of Collagen Fibril Assembly*

  2004cited by this paper
• Collagens, modifying enzymes and their mutations in humans, flies and worms.

  2004cited by this paper
• Prolyl 3-Hydroxylase 1, Enzyme Characterization and Identification of a Novel Family of Enzymes*

  2004influential reference
• Osteogenesis imperfecta.

  2004cited by this paper
• LEPREL1, a novel ER and Golgi resident member of the Leprecan family.

  2004cited by this paper
• Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta.

  2004cited by this paper
• Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.

  2003cited by this paper
• Effect of 3-hydroxyproline residues on collagen stability.

  2003cited by this paper
• Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis.

  2003cited by this paper
• Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease.

  2002cited by this paper
• Osteogenesis imperfecta type VII maps to the short arm of chromosome 3.

  2002cited by this paper
• Osteogenesis Imperfecta Type VI: A Form of Brittle Bone Disease with a Mineralization Defect

  2002cited by this paper
• Type V Osteogenesis Imperfecta: A New Form of Brittle Bone Disease

  2000cited by this paper
• cDNA cloning, characterization and chromosome mapping of Crtap encoding the mouse cartilage associated protein.

  1999cited by this paper
• Cartilage associated protein (CASP) is a novel developmentally regulated chick embryo protein.

  1997cited by this paper
• A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I).

  1996cited by this paper
• A Splice-Junction Mutation in the Region of COL5A1 that Codes for the Carboxyl Propeptide of Proα1(V) Chains Results in the Gravis Form of the Ehlers-Danlos Syndrome (Type I)

  1996cited by this paper
• Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter.

  1990cited by this paper
• Structure and biosynthesis of basement membranes.

  1973cited by this paper
• Osteogenesis Imperfecta.

  year unknowncited by this paper

• A new Col1a1 conditional knock-in mouse model to study osteogenesis imperfecta.

  2024cites this paper
• A view of the genetic and proteomic profile of extracellular matrix molecules in aging and stroke

  2023cites this paper
• Mesenchymal stem cells in the treatment of osteogenesis imperfecta

  2023influential citation
• Craniofacial and dental phenotype of two girls with osteogenesis imperfecta due to mutations in CRTAP.

  2022cites this paper
• Between a rock and a hard place: Regulation of mineralization in the periodontium

  2022cites this paper
• Respiratory defects in the CrtapKO mouse model of Osteogenesis Imperfecta.

  2020cites this paper
• Proteomics analysis of preadipocytes between fat and lean broilers

  2019cites this paper
• Effect of Anti‐TGF‐β Treatment in a Mouse Model of Severe Osteogenesis Imperfecta

  2018cites this paper
• Fkbp10 Deletion in Osteoblasts Leads to Qualitative Defects in Bone

  2017cites this paper
• Bulbous epiphysis and popcorn calcification as related to growth plate differentiation in osteogenesis imperfecta.

  2015cites this paper
• Búsqueda de perfiles moleculares diferenciales entre tolerancia y sensibilización en la respuesta alérgica

  2014cites this paper
• Recessive Osteogenesis Imperfecta Due to Mutations in CRTAP, LEPRE1 and PPIB

  2014cites this paper
• Animal Models of Osteogenesis Imperfecta

  2014cites this paper
• Skeletal diseases caused by mutations that affect collagen structure and function.

  2013cites this paper
• Prenatal diagnosis of osteogenesis imperfecta type II by three‐dimensional computed tomography: The current state of fetal computed tomography

  2012cites this paper
• Putative Multifunctional Signature of Lung Metastases in Dedifferentiated Chondrosarcoma

  2012cites this paper
• Changes associated with lenalidomide treatment in the gene expression profiles of patients with del(5q).

  2012cites this paper
• Protein folding and quality control in the ER.

  2011cites this paper
• Severe osteogenesis imperfecta caused by a small in‐frame deletion in CRTAP

  2011cites this paper